News

-- Projects Seek New Insights into Stopping Progression and Improving Well-Being for People with Progressive MS

The International Progressive MS Alliance, a global initiative in which the National MS Society plays a leading role, launched funding for two major initiatives to address the urgent need for new, effective treatments for people living with progressive MS:

• Six new Challenges in Progressive MS Awards will advance the promising findings from projects funded in 2021 to explore mechanisms that drive progression, an area where current lack of knowledge is hindering treatment development.
• The new grants focus on several areas including novel insights into nerve loss, potential pathways for protecting and repairing nervous system tissues, and testing potential drugs to slow progression.

The second new initiative is the Innovations in Well-Being Awards. These are the first phase of a large-scale program to identify and implement solutions to some of the most challenging symptoms that people with progressive MS experience:

• Nine new awards will enable expert teams to develop, test and implement novel therapeutic interventions.
• The new awards focus on the symptoms of pain, mobility, impaired cognition and fatigue.  The first phase of the research projects will initiate in early 2024 and report results in mid-2025.

Learn more about both new research awards here

These research investments are only the latest of the ongoing work of the International Progressive MS Alliance. The Alliance is an unprecedented global collaboration of MS organizations, researchers, health professionals, the pharmaceutical industry, companies, trusts, foundations, donors and people affected by progressive MS, working together to address the unmet needs of people with progressive MS ─ rallying the global community to find solutions.